A decade after sparking the Seaport’s boom, Vertex is considering leaving Fan Pier
When Vertex Pharmaceuticals moved from Cambridge ... its real estate options — and considering leaving its prominent ...
MoneyWeek on MSN1d
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...
Reuters1mon
Vertex Pharmaceuticals Inc
Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of ...
Vertex’s non-opioid pain drug gets some UnitedHealth coverage
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Hosted on MSN1mon
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
Vertex Pharmaceuticals is a biotech company based in Boston. Its headquarters are in the Seaport neighborhood, and it also has a research site in Cambridge's Kendall Square. The company also has ...
Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Nasdaq3d
Vertex Pharmaceuticals Stock: Is VRTX Outperforming the Healthcare Sector?
Additionally, shares of Vertex Pharmaceuticals have surged 14.7% ... and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's financial district, Barchart ...
Nasdaq16d
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
Focusing on the healthcare sector, Vertex Pharmaceuticals has outpaced the ... do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's financial district ...